|
CMMB Chemomab Therapeutics Ltd - ADR 1534248 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-8,995,000.00 |
| Balance Sheet |
|
Current Assets
|
$13,425,000.00 |
|
Assets
|
$13,812,000.00 |
|
Current Liabilities
|
$1,478,000.00 |
|
Liabilities
|
$1,478,000.00 |
|
Equity
|
$12,334,000.00 |
|
Shares Out
|
413851140.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,130,000.00 |
|
Investing Cash Flow
|
$5,390,000.00 |
| Market Analysis |
Market Cap
|
$633,192,244.20 |
|
Price
|
$1.61 |
|
BVPS
|
0.03 |
|
PB
|
51.00 |
|
EPS
|
0.02 |
|
FCF
|
$-11,133,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CMMB documents filed with the SEC.
CMMB Filings
Clear
